Drug Shortage Report for CELESTONE SOLUSPAN
Report ID | 16797 |
Drug Identification Number | 00028096 |
Brand name | CELESTONE SOLUSPAN |
Common or Proper name | BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | BETAMETHASONE ACETATE BETAMETHASONE |
Strength(s) | 3MG 3MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRA-ARTICULAR INTRABURSAL INTRADERMAL INTRAMUSCULAR |
Packaging size | 1mL |
ATC code | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-09-13 |
Actual start date | 2017-09-15 |
Estimated end date | 2017-09-29 |
Actual end date | 2017-09-28 |
Shortage status | Resolved |
Updated date | 2017-09-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-07-24 | French | Compare |
v1 | 2017-07-24 | English | Compare |